The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I agree with a lot of your post but with regards to post covid I believe that the market needs to see non covid products being produced and being sold in good quantities to warrant a good future investment opportunity. Being in a position to achieve that, which I think we are, is a different proposition to actually producing, as proven by NCYT's pre covid record and hence the need for a new CEO.
You have to ask yourself, would you/or did you consider buying this stock pre covid? Probably not I would guess. This Company has seized this Covid opportunity to very effectively put itself in a very good starting position for the future. Now imho market sentiment sees this and is aware of the pre covid position and know that this level of Covid growth will not go on forever ( example drops on the vaccines, rule relaxations and DHSC dispute) . Yes Novacyt has laid out it's strategy but, at present, it is just that and until the meat starts to appear on those bones of the strategy this sp performance is what we can expect with spikes and drops. Novacyt has played Covid very well and proved their expertise and gained inroads to many markets so, for now, we just have to put up with this situation for a while (short I hope) . Well done to GM for getting this far and good luck to the new boss on developing the future strategy. As an aside MM's do not buy or sell stock, they match buyers with sellers and vice versa and make their money on the spread. Many ways to find enough shares to do this including raising/lowering prices. Without MMs you have no market.
"If you look at Novacyt ,the company right now , and compare it to exactly 12 months ago , then , you will find that it is far more bigger and cash rich now" That was achieved by the BOD!!! What would you have them do, issue BS news like a lot of Life Style Companies on Aim? The BOD's Job is to run a good and profitable Company with plenty of growth prospects which, I believe they are doing, and not to compensate investors who were unfortunate/unlucky in their entry point. Yes the SP is disappointing but that is market sentiment for you which I think, is waiting to see examples of growth in the non covid sector of the company bearing in mind where we were pre covid.
This update needs to give a good concrete picture of Novacyt post Covid. The DHSC dispute settlement may increase the Sp and if that increase holds all well and good but I fear that will also erode. Market sentiment, I believe, needs to be as sure as it can be that Novacyt will not dry up as and when Covid ceases to be a pandemic as can be seen by the step downs in Sp occuring with the vaccines roll out and lockdowns finishing. All in my very humble opinion and yes I am a holder and still in profit albeit nowhere near the profit I was once smiling at.
Hi Kaeren, just for info, my daughter, in the 1990's, contracted cancer and ended up having to have a really aggressive Chemo treatment which would knock out her immune system and require a bone marrow transplant after. Instead of the bone marrow transplant they harvested her stem cells and replaced them after the Chemo. All well now I am happy to say.
Good post JRDC, couldn't agree more. Plenty of money in the bank with more to come and funded expansion to position Novacyt for the future but post Covid is what the market/investors need certainty on, hence the SP.
The management have done pretty well so far, the company fundamentals seem sound and plenty of funds in the war chest, just a little patience. The dip, approx 50% is approx the revenue possibly lost over the the Gov contract, not through lack of info. Yes more positive info might stabilise the SP. Remember the Company are planning for life after the Pandemic as well as during. I am reasonably happy with my position and when I cease to be I shall sell up.
I would imagine that, apart from the contractual dispute which was the issue of an RNS, then nothing of material note has occurred. New products coming online, for example, become of material note as they are taken up and, with the aforementioned contractual dispute and a not up to speed international sales force, this may not have come to the fore as yet. Product updates and the like, I would imagine, would come under the auspices of company news rather than an RNS, but I, along with many others, should like a steady news flow. I speak as someone who is not underwater with this share just at a very reduced profit if I want to take it which I do not.
It would appear to be a bit of confusion here....... A company has to issue an RNS if there is news that will materially effect the share price, be it good or bad. A CEO doesn't get to pick and choose and they also have to pay for the privilege ( not a lot in the scheme of things admittedly).
I do not think that we will get any figures on revenue anytime soon as, and I am not entirely sure about this, the last Dir purchase of shares could be labelled as market abuse in that his purchase would trigger a closed period ie he knew that the increase revenue would be put into the public domain and thus cause a rise in the SP which he could take advantage of. I do not know if this applies to production figures and future orders. I could be totally wrong about this of course.
Comparison of death rates is not helpful, at this stage of the fight against the virus whereas numbers of cases admitted to hospital are. I might enquire why Care Home residents are not admitted to hospital when diagnosed with Covid 19 as they are in a high risk group.
Ex investor in PXS with a couple of Stents fitted and associated medication. Been to the Docs a few times lately for myself and wife and, while there, thought I would check out my BP. Up until the end of last week it was high, ranging between 143 to 155,so what could I do I thought. I went back to FruitFlow and at the Docs again today, down to 128. I know this will be no surprise to the regulars here but I thought I would mention it for anybody new looking in. Product excellent but nothing more to add.